Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-25-002133
Filing Date
2025-08-12
Accepted
2025-08-12 09:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7394
  Complete submission text file 0000950142-25-002133.txt   8889
Mailing Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428
Business Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 610-540-7515
Medicus Pharma Ltd. (Subject) CIK: 0001997296 (see all company filings)

EIN.: 981778211 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94797 | Film No.: 251204313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 KING ST W SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
Melani Kenneth R. (Filed by) CIK: 0002050471 (see all company filings)

Type: SCHEDULE 13G/A